Answers are grounded in this paper and cite their sources.
With large enough sample sizes, GFR slope may be a viable surrogate for clinical end points in CKD RCTs.
No takes yet. Share an insight, caveat, or question.
Inker et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: